In parallel, we investigated the cumulative expression of Fas ligand (FasL) on the T cell membrane, indicating the likelihood for ligand-based cytotoxicity, after tumor encounter in HER2-CAR T cells (Fig. 5M and fig. The gene discussed is ERBB2; the disease is neoplasm.